MBL Wealth LLC Sells 245 Shares of CME Group Inc. $CME

MBL Wealth LLC decreased its position in CME Group Inc. (NASDAQ:CME) by 18.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,068 shares of the financial services provider’s stock after selling 245 shares during the quarter. MBL Wealth LLC’s holdings in CME Group were worth $283,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Geneos Wealth Management Inc. grew its stake in shares of CME Group by 23.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 4,421 shares of the financial services provider’s stock valued at $1,173,000 after buying an additional 831 shares in the last quarter. Fortis Capital Advisors LLC bought a new stake in shares of CME Group in the 1st quarter valued at approximately $1,016,000. Belpointe Asset Management LLC grew its stake in shares of CME Group by 88.9% in the 1st quarter. Belpointe Asset Management LLC now owns 6,787 shares of the financial services provider’s stock valued at $1,801,000 after buying an additional 3,195 shares in the last quarter. Focus Partners Wealth grew its stake in shares of CME Group by 5.9% in the 1st quarter. Focus Partners Wealth now owns 175,537 shares of the financial services provider’s stock valued at $46,544,000 after buying an additional 9,703 shares in the last quarter. Finally, Ransom Advisory Ltd bought a new stake in shares of CME Group in the 1st quarter valued at approximately $31,000. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 256 shares of the business’s stock in a transaction dated Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director directly owned 258,196 shares in the company, valued at $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Oppenheimer upped their target price on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Barclays set a $298.00 target price on CME Group and gave the stock an “equal weight” rating in a research report on Thursday, July 24th. Piper Sandler upped their target price on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Finally, Citigroup upped their target price on CME Group from $265.00 to $275.00 and gave the stock a “neutral” rating in a research report on Thursday, July 3rd. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $260.60.

CME Group Stock Down 0.6%

Shares of CME stock opened at $259.91 on Thursday. CME Group Inc. has a 12 month low of $212.38 and a 12 month high of $290.79. The firm has a market cap of $93.67 billion, a PE ratio of 25.16, a price-to-earnings-growth ratio of 4.73 and a beta of 0.43. The stock has a 50 day moving average of $274.10 and a 200-day moving average of $270.11. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the company earned $2.56 earnings per share. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s payout ratio is 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.